The global Prostaglandin I2 market size is expected to reach $ 3808.7 million by 2029, rising at a market growth of 6.0% CAGR during the forecast period (2023-2029).
Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.
This report studies the global Prostaglandin I2 production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prostaglandin I2, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostaglandin I2 that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prostaglandin I2 total production and demand, 2018-2029, (K Units)
Global Prostaglandin I2 total production value, 2018-2029, (USD Million)
Global Prostaglandin I2 production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prostaglandin I2 consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Prostaglandin I2 domestic production, consumption, key domestic manufacturers and share
Global Prostaglandin I2 production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Prostaglandin I2 production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prostaglandin I2 production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Prostaglandin I2 market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, J & J, GSK, Teva, Toray, Tide Pharma and Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prostaglandin I2 market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Prostaglandin I2 Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Prostaglandin I2 Market, Segmentation by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Global Prostaglandin I2 Market, Segmentation by Application
For Injection
For Oral
For Inhalation
Companies Profiled:
United Therapeutics
J & J
GSK
Teva
Toray
Tide Pharma
Bayer AG
Key Questions Answered
1. How big is the global Prostaglandin I2 market?
2. What is the demand of the global Prostaglandin I2 market?
3. What is the year over year growth of the global Prostaglandin I2 market?
4. What is the production and production value of the global Prostaglandin I2 market?
5. Who are the key producers in the global Prostaglandin I2 market?
6. What are the growth factors driving the market demand?
Summary:
Get latest Market Research Reports on Prostaglandin I2 . Industry analysis & Market Report on Prostaglandin I2 is a syndicated market report, published as Global Prostaglandin I2 Supply, Demand and Key Producers, 2023-2029. It is complete Research Study and Industry Analysis of Prostaglandin I2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.